Shanghai’s Science District Spotlights Chinese Biotech Surge And Global Investor Interest

SHANGHAI — The biotech executives appeared triumphant.

It was a balmy, overcast Sunday here in the glimmer‑and‑glass “Science City” district, and the four leaders were on stage at the ballroom level of the five‑star Hilton, joking about how much faster, cheaper, and more efficient drug development was here in China than anywhere else — certainly than the United States. (And God help Europe.)

STAT+ Exclusive Story

Already have an account? Log in

                                    }

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

View All Plans

// continue remaining promotional fragments unchanged

To read the rest of this story subscribe to STAT+.

Subscribe

Clean
Subscribe

Subscribe

// Note: All media tags () and embedded URLs are left exactly as in the source.

Source link